TG Therapeutics, Inc. (TGTX)

54.53 +1.23 (+2.31%) USD  |  NASDAQ  |  Oct 20, 16:00
54.50 -0.03 (-0.06%) After-Hours: 07:38
More

TG Therapeutics Gross Profit (TTM) : 658.60M for June 30, 2026

Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 658.60M
March 31, 2026 581.67M
December 31, 2025 515.52M
September 30, 2025 453.81M
June 30, 2025 394.67M
March 31, 2025 337.55M
December 31, 2024 290.24M
September 30, 2024 233.54M
June 30, 2024 321.25M
March 31, 2024 270.23M
December 31, 2023 219.11M
September 30, 2023 183.03M
June 30, 2023 20.82M
March 31, 2023 7.179M
December 31, 2022 2.133M
September 30, 2022 4.293M
June 30, 2022 6.068M
March 31, 2022 7.025M
December 31, 2021 5.90M
September 30, 2021 3.721M
June 30, 2021 1.927M
March 31, 2021 0.478M
December 31, 2020 -2.223M
September 30, 2020 -2.19M
June 30, 2020 -2.122M
Date Value
March 31, 2020 -2.055M
December 31, 2019 0.007M
September 30, 2019 0.056M
June 30, 2019 0.059M
March 31, 2019 0.061M
December 31, 2018 0.064M
September 30, 2018 0.0677M
June 30, 2018 0.0699M
March 31, 2018 0.0699M
December 31, 2017 0.0699M
September 30, 2017 0.0698M
June 30, 2017 0.0716M
March 31, 2017 0.0757M
December 31, 2016 0.0894M
September 30, 2016 0.0718M
June 30, 2016 0.0529M
March 31, 2016 0.0317M
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Krystal Biotech, Inc. 411.03M
Vertex Pharmaceuticals, Inc. 10.94B
SELLAS Life Sciences Group, Inc. 0.00
Travere Therapeutics, Inc. 519.70M
Alnylam Pharmaceuticals, Inc. 3.827B